Cost
$20000
Bone Marrow Transplant in India is a state-of-the-art and accessible medical treatment. From the complete range of pre-transplant tests to post-transplant recuperation, Indian hospitals provide quality-conscious, cost-effective treatment. It is much cheaper than in Western countries, yet it retains international levels of safety and success.
Bone Marrow Transplant (BMT) is a serious, sometimes life-saving treatment for patients who have poor blood disorders and some forms of cancer. With India becoming a healthcare hub for the world, BMT operations in India are gaining momentum because of their high success rate, low cost, and state-of-the-art facilities. Depending on the type, the cost of BMT in India ranges from USD 20,000 to USD 45,000.
As of 2024, India performs more than 2,500 BMTs every year, with key hospitals achieving success rates ranging from 60% to 90?sed on the type of disease and condition of the patient. Foreigners from Africa, the Middle East, Southeast Asia, and even developed nations are opting for bone marrow transplant in India, giving credit to economic factors and clinical superiority.
Bone marrow is a soft, fatty substance within bones in which blood cells are manufactured. They consist of:
When this marrow is injured or doesn't work because of diseases such as leukemia, lymphoma, or aplastic anemia, a transplant must be done. BMT consists of replacing the diseased or damaged marrow with healthy hematopoietic (blood-producing) stem cells from the patient or from a donor. These stem cells have the ability to form the whole blood and immune system.
BMT is of the following four types:
In Autologous BMT, the stem cells are harvested from the patient, preserved, and re-infused later after heavy doses of chemotherapy or radiation. This is the best option when the marrow itself is not diseased, e.g., in:
In Allogeneic BMT, the stem cells are taken from a donor whose tissue type is very similar to the patient's. This is more complex, but it is the best treatment for diseases where the marrow itself is ill:
Haploidentical BMT is a kind of allogeneic transplant in which the donor is only half a match, often a parent or sibling. Developments in immune-suppressive treatments have allowed this to become an acceptable and growing reality.
In an umbilical cord blood transplant, the stem cells from a newborn's umbilical cord are harvested. While the cell count is lower, they are more versatile, and there is less risk of rejection.
A BMT can be suggested for patients with:
Eligibility Criteria:
A transplant team performs a complete physical examination, review of medical history, and diagnostic tests to evaluate candidacy.
Both the patient and the donor (if concerned) have extensive tests done before BMT:
Conditioning Regimen:
High-dose chemotherapy and/or radiation is given to kill diseased cells and put the immune system to sleep to allow new stem cells to be accepted.
Medical tourism facilitators like NeuHealth provide BMT packages that include:
Their packages also include:
Patients from all over the world choose India for BMT because of a number of reasons, including but not limited to the following:
NABH and JCI-accredited centers with dedicated transplant units
Hematologists and transplant surgeons trained in the US, UK, and Europe
Cost is 70-80% lower compared to the West
Organizations like DATRI and Jeevan offer donor matching
Patients can start treatment shortly after examination
International patients need to verify with their insurance provider for coverage abroad. Indian hospitals accept a range of international insurance policies or have arrangements with TPAs for billing.
India provides an efficient Medical Visa (M Visa) facility for patients. Documents needed are:
Hospitals and medical tourism facilitators offer:
Depending on the type, the cost of BMT in India ranges from USD 20,000 to USD 45,000. The cost also depends on other factors such as hospital type, surgeon's expertise, post-op hospital stay, etc.
Breakdown:
The cost of BMT in India is influenced by a variety of factors, including but not limited to the following:
| Country | Autologous BMT (USD) | Allogeneic BMT (USD) |
| India | USD 20,000 - USD 25,000 | USD 30,000 - USD 40,000 |
| Turkey | USD 40,000 - USD 60,000 | USD 70,000 - USD 100,000 |
| Thailand | USD 35,000 - USD 55,000 | USD 60,000 - USD 90,000 |
| UK | USD 120,000 - USD 180,000 | USD 250,000 - USD 400,000 |
| USA | USD 100,000 - USD 250,000 | USD 300,000 - USD 800,000 |
Undergoing a bone marrow transplant is a multi-phase journey that spans preparation, hospital stay, and long-term recovery. Each phase is carefully managed to ensure successful engraftment and minimize complications.
Recovery after a bone marrow transplant is gradual and varies by individual. It involves close monitoring, infection prevention, immune system rebuilding, and long-term follow-up care to ensure sustained recovery and overall well-being.
Patients worldwide still opt for India for BMT based on its clinical experience, infrastructure, cost transparency, and patient care. For leukemia, thalassemia, or immune deficiency, India has been a proven destination for this intricate life-saving treatment.
Transparent · Professional · Without Hassles
Book Doctor Appointment
Consult on Video or in-person at Hospital
Compare Cost Estimates
Hospitalisation Support
Our services are FREE and by using our services your hospital bill does not increase!
Yes, India has internationally trained hematologists, advanced transplant ICUs, and strict infection control protocols ensuring high safety standards.
Success rates of BMT in India range from 60% to 90%, depending on the disease, donor match, and patient health.
Patients typically stay 21 to 35 days, including isolation and close monitoring.
Autologous BMT costs around USD 20,000 to 25,000, while allogeneic or haploidentical BMT costs USD 30,000 to 40,000.
Yes, India treats thousands of global patients each year and offers complete support with visas, donor matching, and long-term follow-ups.
Autologous, Allogeneic, Haploidentical, Matched Sibling Donor, and Unrelated Donor BMTs are all offered in India.
Initial recovery takes 3 to 6 months, and complete immune recovery may take up to 1 year.
India allows only related donors, but partial-match (haploidentical) transplants provide a strong alternative for many families.
Infections, GVHD (Graft-versus-Host Disease), and low blood counts are all manageable under experienced transplant teams.
Most international patients can fly 6 to 8 weeks after transplant, depending on stability and doctor clearance.
